• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛磺石胆酸盐对大鼠体内对乙酰氨基酚硫酸化和葡萄糖醛酸化的影响。

Effect of taurolithocholate on in vivo sulfation and glucuronidation of acetaminophen in rats.

作者信息

Galinsky R E, Chałasinska B

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Utah, Salt Lake City 84112.

出版信息

Pharm Res. 1988 Jan;5(1):61-4. doi: 10.1023/a:1015871713954.

DOI:10.1023/a:1015871713954
PMID:3244612
Abstract

Taurolithocholate produces a prompt, complete, and reversible cessation of bile flow in rats. This is associated with impaired hepatic oxidative drug-metabolizing activity. The purpose of this study was to examine the effects of taurolithocholate-induced cholestasis on in vivo conjugation. The pharmacokinetics of acetaminophen and the two major processes specifically responsible for its elimination, namely, the formations of acetaminophen sulfate and acetaminophen glucuronide, were used to assess hepatic conjugating activity. A 30-mg/kg bolus of acetaminophen was administered intravenously to rats 2 hr (acute cholestasis) or 20 hr (postcholestasis) after intravenous pretreatment with sodium taurolithocholate, 5 mumol/100 g body weight. Acute cholestasis increased the total clearance of acetaminophen 20%, the partial clearance to acetaminophen sulfate 12%, and the partial clearance to acetaminophen glucuronide 85%. Postcholestasis, these parameters had significantly decreased compared to those during acute cholestasis and were comparable to control values. The results show that cholestasis does not impair acetaminophen conjugation in the rat.

摘要

牛磺石胆酸盐可使大鼠胆汁流动迅速、完全且可逆地停止。这与肝脏氧化药物代谢活性受损有关。本研究的目的是研究牛磺石胆酸盐诱导的胆汁淤积对体内结合作用的影响。对乙酰氨基酚的药代动力学以及专门负责其消除的两个主要过程,即对乙酰氨基酚硫酸盐和对乙酰氨基酚葡萄糖醛酸苷的形成,被用于评估肝脏结合活性。在用5 μmol/100 g体重的牛磺石胆酸钠静脉预处理大鼠2小时(急性胆汁淤积)或20小时(胆汁淤积后)后,给大鼠静脉注射30 mg/kg的对乙酰氨基酚。急性胆汁淤积使对乙酰氨基酚的总清除率增加了20%,对乙酰氨基酚硫酸盐的部分清除率增加了12%,对乙酰氨基酚葡萄糖醛酸苷的部分清除率增加了85%。胆汁淤积后,与急性胆汁淤积期间相比,这些参数显著降低,且与对照值相当。结果表明,胆汁淤积不会损害大鼠体内对乙酰氨基酚的结合作用。

相似文献

1
Effect of taurolithocholate on in vivo sulfation and glucuronidation of acetaminophen in rats.牛磺石胆酸盐对大鼠体内对乙酰氨基酚硫酸化和葡萄糖醛酸化的影响。
Pharm Res. 1988 Jan;5(1):61-4. doi: 10.1023/a:1015871713954.
2
Inhibition of hepatic Na +, K + -adenosinetriphosphatase in taurolithocholate-induced cholestasis in the rat.牛磺石胆酸诱导的大鼠胆汁淤积中肝钠钾 - 三磷酸腺苷酶的抑制作用
Experientia. 1979 Sep 15;35(9):1186-8. doi: 10.1007/BF01963278.
3
Effect of inhibition of protein synthesis on cholestasis induced by taurolithocholate, lithocholate, and a manganese-bilirubin combination in the rat.蛋白质合成抑制对牛磺石胆酸、石胆酸及锰-胆红素组合诱导的大鼠胆汁淤积的影响。
Biochem Pharmacol. 1989 Aug 1;38(15):2543-9. doi: 10.1016/0006-2952(89)90100-7.
4
Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver.牛磺熊去氧胆酸盐可预防牛磺石胆酸盐诱导的大鼠肝脏胆汁淤积和毒性。
J Hepatol. 1990 May;10(3):280-3. doi: 10.1016/0168-8278(90)90133-c.
5
Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.牛磺石胆酸在大鼠肝脏逆向灌注期间胆汁淤积效力降低。
Lab Invest. 1987 Jun;56(6):576-82.
6
Taurolithocholate-induced intrahepatic cholestasis: potentiation by methyl isobutyl ketone and methyl n-butyl ketone in rats.
Toxicol Appl Pharmacol. 1985 Sep 15;80(2):228-34. doi: 10.1016/0041-008x(85)90079-1.
7
Taurolithocholate increases heme catabolism and alters the clearance of antipyrine in the rat.
Gastroenterology. 1985 Feb;88(2):397-402. doi: 10.1016/0016-5085(85)90498-6.
8
Cholestasis and the interactions of sulfated glyco- and taurolithocholate with calcium.
Am J Physiol. 1988 May;254(5 Pt 1):G644-9. doi: 10.1152/ajpgi.1988.254.5.G644.
9
Effect of chronic administration of taurolithocholate on bile formation and liver ultrastructure in the rat.
Liver. 1987 Jun;7(3):130-7. doi: 10.1111/j.1600-0676.1987.tb00332.x.
10
Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats.石胆酸盐和牛磺石胆酸盐诱导大鼠肝内胆汁淤积的发病机制。
Gastroenterology. 1978 Oct;75(4):595-607.

引用本文的文献

1
Pharmacokinetics in the child.儿童的药代动力学。
Environ Health Perspect. 1994 Dec;102 Suppl 11(Suppl 11):111-7. doi: 10.1289/ehp.94102s11111.

本文引用的文献

1
CHRONIC INTRAVENOUS CANNULAS FOR RATS.大鼠慢性静脉插管
J Appl Physiol. 1964 May;19:540-1. doi: 10.1152/jappl.1964.19.3.540.
2
Diurnal variation in mouse and rat liver sulfhydryl.小鼠和大鼠肝脏巯基的昼夜变化。
Proc Soc Exp Biol Med. 1958 Jan;97(1):229-31. doi: 10.3181/00379727-97-23698.
3
Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones.石胆酸硫酸化作为胆结石患者中鹅去氧胆酸诱导血清转氨酶升高的一种可能调节因素。
J Clin Invest. 1981 Nov;68(5):1190-6. doi: 10.1172/jci110364.
4
Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.大鼠体内对乙酰氨基酚的剂量和时间依赖性消除:共底物耗竭的药代动力学意义。
J Pharmacol Exp Ther. 1981 Oct;219(1):14-20.
5
Diurnal variation of rat liver enzymes catalyzing bile acid conjugation and sulfation.
Biochim Biophys Acta. 1980 Dec 5;620(3):627-30. doi: 10.1016/0005-2760(80)90154-x.
6
Multiple testing of hypotheses in comparing two groups.两组比较中的多重假设检验。
Ann Intern Med. 1984 Jan;100(1):122-9. doi: 10.7326/0003-4819-100-1-122.
7
Biochemical and morphological parameters of taurolithocholate-induced cholestasis.牛磺石胆酸诱导的胆汁淤积的生化和形态学参数。
Can J Physiol Pharmacol. 1971 Dec;49(12):1078-91. doi: 10.1139/y71-153.
8
Daily rhythmic variation in hepatic drug metabolism in the rat and mouse.大鼠和小鼠肝脏药物代谢的每日节律变化。
J Pharmacol Exp Ther. 1968 Sep;163(1):229-38.
9
Effect of subchronic cholestasis on microsomal mixed-function oxidases and the glutathione-conjugating enzyme system in rat liver.
Pharmacol Res Commun. 1985 Sep;17(9):841-6. doi: 10.1016/0031-6989(85)90042-6.
10
Effects of N-acetylcysteine on the disposition and metabolism of acetaminophen in mice.N-乙酰半胱氨酸对小鼠体内对乙酰氨基酚处置和代谢的影响。
J Pharmacol Exp Ther. 1985 Mar;232(3):857-63.